Benatton Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
- Satisfied Charges ₹ 11.90 Cr
- Revenue Growth 22.46%
- Profit Growth 58.46%
- Ebitda 77.15%
- Net Worth 145.91%
- Total Assets 8.22%
About Benatton Pharmaceutical
Benatton Pharmaceutical Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2020 (Four years and 11 months 9 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹11.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vipul Jain, Deepak Oswal, Subodh Dubey, and One other member serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299PN2020PTC190386
- Company No.
190386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Benatton Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Oswal  | Managing Director | 16-Mar-2020 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vipul Jain | Director | 16-Mar-2020 | Current |
| Subodh Dubey | Director | 16-Mar-2020 | Current |
| Reena Dubey | Director | 16-Mar-2020 | Current |
Financial Performance of Benatton Pharmaceutical.
Benatton Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.46% increase. The company also saw a substantial improvement in profitability, with a 58.46% increase in profit. The company's net worth Soared by an impressive increase of 145.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Benatton Pharmaceutical?
In 2023, Benatton Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wellness Maxcare Private LimitedVipul Jain and Deepak Oswal are mutual person
Charges (Loans)
₹100.00 M
₹119.00 M
Charges Breakdown by Lending Institutions
- Others : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2023 | Others | ₹10.00 Cr | Open |
| 06 Mar 2021 | Others | ₹7.00 Cr | Satisfied |
| 30 Dec 2020 | Others | ₹9.00 M | Satisfied |
| 10 Jul 2020 | Others | ₹4.00 Cr | Satisfied |
How Many Employees Work at Benatton Pharmaceutical?
Benatton Pharmaceutical has a workforce of 9 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Benatton Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Benatton Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.